edoc

Items where Author is "Bokemeyer, Carsten"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2019 | 2017 | 2010
Number of items: 9.

2019

Ludwig, Heinz and Bokemeyer, Carsten and Aapro, Matti and Boccadoro, Mario and Gascon, Pere and Denhaerynck, Kris and Krendyukov, Andriy and Abraham, Ivo and MacDonald, Karen. (2019) Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study. Future Oncology, 15 (8). pp. 897-908.

Ludwig, Heinz and Gascón, Pere and Bokemeyer, Carsten and Aapro, Matti and Boccadoro, Mario and Denhaerynck, Kris and Krendyukov, Andriy and MacDonald, Karen and Abraham, Ivo. (2019) Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated "same-day" ( 72 h): findings from the MONITOR-GCSF study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 27 (6). pp. 2301-2312.

2017

Aapro, Matti and Bokemeyer, Carsten and Ludwig, Heinz and Gascón, Pere and Boccadoro, Mario and Denhaerynck, Kris and Gorray, Michael and Krendyukov, Andriy and MacDonald, Karen and Abraham, Ivo. (2017) Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study). Journal of geriatric oncology, 8 (2). pp. 86-95.

Bokemeyer, Carsten and Gascón, Pere and Aapro, Matti and Ludwig, Heinz and Boccadoro, Mario and Denhaerynck, Kris and Gorray, Michael and Krendyukov, Andriy and Abraham, Ivo and MacDonald, Karen. (2017) Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study. Supportive Care in Cancer, 25 (6). pp. 1819-1828.

2010

Choschzick, Matthias and Lassen, Paula and Lebeau, Annette and Marx, Andreas Holger and Terracciano, Luigi and Heilenkötter, Uwe and Jaenicke, Fritz and Bokemeyer, Carsten and Izbicki, Jakob and Sauter, Guido and Simon, Ronald. (2010) Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome. Modern pathology, Vol. 23, no. 4. pp. 603-610.

Marx, Andreas H. and Burandt, Eike C. and Choschzick, Matthias and Simon, Ronald and Yekebas, Emre and Kaifi, Jussuf T. and Mirlacher, Martina and Atanackovic, Djordje and Bokemeyer, Carsten and Fiedler, Walter and Terracciano, Luigi and Sauter, Guido and Izbicki, Jakob R.. (2010) Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers. Human pathology, Vol. 41, H. 11. pp. 1577-1585.

Choschzick, Matthias and Lebeau, Annette and Marx, Andreas H. and Tharun, Lars and Terracciano, Luigi and Heilenkötter, Uwe and Jaenicke, Fritz and Bokemeyer, Carsten and Simon, Ronald and Sauter, Guido and Schwarz, Jörg. (2010) Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer. Human pathology, Vol. 41, H. 3. pp. 358-365.

Engert, Andreas and Plütschow, Annette and Eich, Hans Theodor and Lohri, Andreas and Dörken, Bernd and Borchmann, Peter and Berger, Bernhard and Greil, Richard and Willborn, Kay C. and Wilhelm, Martin and Debus, Jürgen and Eble, Michael J. and Sökler, Martin and Ho, Antony and Rank, Andreas and Ganser, Arnold and Trümper, Lorenz and Bokemeyer, Carsten and Kirchner, Hartmut and Schubert, Jörg and Král, Zdenek and Fuchs, Michael and Müller-Hermelink, Hans-Konrad and Müller, Rolf-Peter and Diehl, Volker. (2010) Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. The New England journal of medicine, Vol. 363, H. 7. pp. 640-652.

Minner, Sarah and Kilgué, Adisa and Stahl, Phillip and Weikert, Steffen and Rink, Michael and Dahlem, Roland and Fisch, Margit and Höppner, Wolfgang and Wagner, Walter and Bokemeyer, Carsten and Terracciano, Luigi and Simon, Ronald and Sauter, Guido and Wilczak, Waldemar. (2010) Y chromosome loss is a frequent early event in urothelial bladder cancer. Pathology, Vol. 42, H. 4. pp. 356-359.

This list was generated on Fri Apr 26 14:02:15 2024 CEST.